Painceptor Pharma Corp. Announces Collaboration With Argenta Discovery Ltd.

PainCeptor Pharma Corp., a biopharmaceutical company focused on the development of novel therapeutics for the treatment of chronic and acute pain, today announced that it has entered into a development collaboration with Argenta Discovery Ltd., a contract and respiratory drug development company. Under the terms of the agreement, scientists from the two companies will exploit Argenta's expertise in computer-aided drug design (CADD) and medicinal chemistry to accelerate PainCeptor's ASIC (acid-sensing ion channel) development program for pain therapeutics, targeting these sensory mechanisms which are associated with a variety of pain-related conditions, including cancer and arthritis.